Science minister Patrick Vallance has admitted that the price the NHS pays for medicines will have to rise in order to win back drug companies’ investment.
Vallance also said that demands from US president Donald Trump for international drug price parity are a “big factor” in the dispute.
When US pharmaceutical giant Merck halted construction on its £1bn London research centre earlier this month it became the latest …
